Century Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Century Therapeutics generated cash of -$88,348,000, which is less than the previous year. Cash used in financing activities reached the amount of -$9,725,000 last year. Net change in cash is therefore -$36,941,000.
Cash Flow
| 2019 | -16.16M | -19.83M | 74.83M |
|---|---|---|---|
| 2020 | -41.26M | -22.75M | 47.69M |
| 2021 | -89.00M | -298.33M | 417.77M |
| 2022 | 14.05M | -13.12M | 27.15M |
| 2023 | -88.34M | 61.13M | -9.72M |
IPSC Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 86.24M | 58.16M | 27.72M | 44.06M | 31.42M |
Operating activities | |||||
Net income | -136.67M | -130.93M | -95.82M | -53.57M | -244.76M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 13.04M | 8.44M | 3.74M | 1.40M | 249K |
Stock-based compensation expense | 14.62M | 10.66M | 4.66M | 876K | 147K |
| Deferred income tax benefit | 14.62M | 10.66M | 4.66M | 876K | 147K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -2.36M | -4.78M | -1.84M | 2.06M | 1.23M |
Cash generated by operating activities | -88.34M | 14.05M | -89.00M | -41.26M | -16.16M |
Investing activities | |||||
Purchases Of Investments | -209.03M | -254M | -330.03M | -49.86M | -41.54M |
Investments In Property Plant And Equipment | -13.73M | -30.60M | -44.97M | -9.82M | -2.46M |
Acquisitions Net | 0 | -238.21M | -30.33M | -4.72M | 24.16M |
Cash generated by investing activities | 61.13M | -13.12M | -298.33M | -22.75M | -19.83M |
Financing activities | |||||
Common Stock Issued | 516K | 27.15M | 221.61M | 38.1M | 74.83M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -10.24M | 0 | 0 | -9.73M | 0 |
Cash used in financing activities | -9.72M | 27.15M | 417.77M | 47.69M | 74.83M |
Net Change In Cash | -36.94M | 28.08M | 30.43M | -16.33M | 38.83M |
Cash at end of period | 49.30M | 86.24M | 58.16M | 27.72M | 70.26M |
| Data source | Data source | Data source |